Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 43,980 | 36,090 | 42,031 | 40,209 | 47,019 |
| Operating Income | -43,980 | -36,090 | -35,178 | -40,209 | -47,019 |
| Interest Expense | 2,525 | 2,529 | 2,570 | 2,541 | 2,450 |
| Other Income | 3,394 | 1,054 | 2,055 | 1,276 | 532 |
| Pre-tax Income | -43,111 | -37,565 | -35,693 | -41,474 | -48,937 |
| Income Tax | 705 | 481 | 1,144 | -2,826 | -24,051 |
| Net Income Continuous | -43,816 | -38,046 | -36,837 | -38,648 | -24,886 |
| Net Income | $-43,816 | $-38,046 | $-36,837 | $-38,648 | $-24,886 |
| EPS Basic Total Ops | -0.40 | -0.38 | -0.38 | -0.40 | -0.26 |
| EPS Basic Continuous Ops | -0.40 | -0.38 | -0.38 | -0.40 | -0.26 |
| EPS Diluted Total Ops | -0.40 | -0.38 | -0.38 | -0.40 | -0.26 |
| EPS Diluted Continuous Ops | -0.40 | -0.38 | -0.38 | -0.40 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.40 | -0.38 | -0.38 | N/A | N/A |
| EBITDA(a) | $-43,744 | $-35,850 | $-41,785 | $-39,971 | $-46,782 |